On the third page of the Korean packet, in a footnote printed smaller than the text around it, she found the sentence that changed the shape of the whole deal. It said that the core patent for the battery-control module, the patent on which the division's value most depended, was not owned by Hanbit at all. It was licensed from the Busan Institute of Technology. The license would expire in eighteen months. And any transfer of control over the division required the Institute's written consent.
She read the footnote three times. She checked each word against the dictionary she kept on her shelf, the one her grandmother had given her, and she wrote down, in her notebook, exactly what the footnote said and exactly what it did not say. It did not say the license could not be renewed. It did not say the Institute would refuse consent. It said only that consent was required, that the clock was running, and that no consent had been sought or recorded in the documents she had been given. That was enough. A summary that said "unencumbered title to all core patents" was not a summary of that footnote. It was a different statement about a different world, a world in which the footnote did not exist.
She kept reading. The packet's second half concerned testing and certification, and here the Korean was denser, full of terms about cell arrays and thermal thresholds that she understood in outline but would not have pretended to judge. What she could judge was what the documents said about who had done the testing. The English summary said the module had received independent certification. The Korean record named the certifying body: Pacific Test Labs, of Portland, Oregon. It described Pacific Test Labs as independent. It did not say who funded it.
Selma did not know who funded Pacific Test Labs, and she did not guess. She wrote down the name, and the claim, and the fact that the packet contained no ownership information about the lab, and she put a question mark beside it in her notebook. Then she called Kara Nilsen.
"I found something," Selma said. "I need to be careful about what I claim. The footnote says the core patent is licensed, not owned, and that consent is required for a transfer. The summary says unencumbered title. Those two things cannot both be true. The second thing is a question, not a finding: the summary says the certification was independent, and the lab is called Pacific Test Labs, but the packet does not show who owns it. I need someone who can look that up."
Kara was quiet for a moment. "That is exactly the right way to say it," she said. "You are not claiming fraud. You are claiming a difference between two documents, and you are asking for a fact that can be checked. Do you want me to find someone who can check the lab?"
"I want the finding to be judged by evidence," Selma said. "If the lab is independent, then that part of my review is wrong, and I will say so. If it is not, then the summary has a second problem."
Kara called a contact at Northgate, a deal-team associate named Jack Corbin, thirty-eight, who had a reputation for being thorough and for disliking rooms where people clapped before the work was done. Corbin, when he heard the question, did not argue. He said he would look up Pacific Test Labs in the public filings, and he called back within two hours.
"Pacific Test Labs," Corbin said, "is majority-funded through a shell company called Meridian Bay Holdings." He paused. "Meridian Bay Holdings is funded by Northgate's venture arm. The venture arm does not control the lab day to day, but it provides most of its money, and it appoints two of its five board members. I would not call that independent. I would call it a conflict that should have been disclosed."
Selma wrote that down too, with the time, and with Corbin's name beside it, because a fact with a name attached to it was harder to dissolve than a fact floating free. She also wrote down what Corbin said next, which was that the genuinely independent laboratory, the Busan laboratory whose report the deal team had been waiting for, had not yet issued its final report when the summary was sent. The summary had been sent anyway.
"Who knew?" Selma asked.
"At least four people," Corbin said. "The compliance officer flagged it. The program director said the work was essentially done and not to delay. The deal team used the summary. And Reid read the summary. Whether he read the footnote is a different question, and I will not answer it for him."